espress加速器

The AIM-HI’s Women’s Venture Competition is a high-profile initiative among women-led oncology start-up companies or venture teams aspiring to soon establish firms. Learn more…

espress加速器

Most venture capital funds claim to engage in “active management,” while in fact doing little more than assuming passive board roles. AIM-HI is actively involved with each of its portfolio companies. Learn more…

espress加速器

AIM-HI draws startups from the deep pipeline of National Foundation for Cancer Research (NFCR) funded scientists and the best-in-class global scientist-entrepreneur community. Learn more…

espress加速器

The AIM-HI Accelerator Fund is an independent 501(C)(3) non-profit organization, established with an initial grant from the National Foundation for Cancer Research with the vision to accelerate the translation of cancer drug discoveries by investing in seed-stage companies. It is a new paradigm through venture philanthropy to fund start-up oncology companies that commercialize innovative laboratory breakthroughs which can potentially save cancer patients’ lives.